CAS
AMIX

Coppell Advisory Solutions’s Autonomix Medical AMIX Stock Holding History

Coppell Advisory Solutions’s Portfolio AMIX Stock Details AMIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2
Closed -$3.73K – 2093
2024
Q3 		$3.73K Hold
2
– – ﹤0.01% 1323
2024
Q2 		$3.73K Buy
+2
New +$1.98K ﹤0.01% 1265

Other funds holding AMIX

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $559M AUM 21.55% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $5.64B AUM
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Coppell Advisory Solutions's AMIX Position: Q4 2024 in Review

Coppell Advisory Solutions sold out of Autonomix Medical (AMIX) in Q4 2024, closing a stake of 2 shares — an estimated $3.73K sold.

Coppell Advisory Solutions first reported a position in AMIX in Q2 2024 and held it in 2 quarters. The position peaked at $3.73K in Q3 2024. 8 funds tracked by Wall St. Rank hold AMIX as of Q4 2024.

  • Coppell Advisory Solutions reported no remaining Autonomix Medical position as of Q4 2024 after selling out during the quarter.
  • Coppell Advisory Solutions sold 2 Autonomix Medical shares in Q4 2024, an estimated $3.73K.
  • Coppell Advisory Solutions first reported a position in Autonomix Medical in Q2 2024 and held it in 2 quarters.
  • Coppell Advisory Solutions's Autonomix Medical position peaked at $3.73K in Q3 2024.
  • 8 funds tracked by Wall St. Rank held Autonomix Medical as of Q4 2024.

Based on Coppell Advisory Solutions's 13F filing for Q4 2024, filed 14 Feb 2025.